Foundation News

Stay up-to-date with the most current news and information about the Crohn's & Colitis Foundation, as well as Crohn's disease and ulcerative colitis.

Researchers receive funding award to compare targeted treatment approaches to improve long-term outcomes in patients with IBD

NEW YORK, NY – Crohn’s disease and ulcerative colitis, also known as inflammatory bowel disease (IBD), affect millions of Americans and can significantly impair patient quality of life.

October 14, 2021

Crohn’s & Colitis Foundation receives $3 million donation to advance precision medicine in IBD

New York, NY -- The Crohn’s & Colitis Foundation (the Foundation) announced today that it received a $3 million donation from Jonathan D. Rose, MD, PhD, to support two major Foundation research programs: IBD-SIRCQ, a national, prospective surgical cohort, and the Jonathan D.

September 14, 2021

Prevention Magazine: Gut Reactions

Kate Kareha keeps a folder in her attic filled with notes, doctor's appointment summaries, photocopies of books, and flyers about inflammation.

August 27, 2021

Crohn’s & Colitis Foundation Recognizes 16 Healthcare Providers with Uniting to Care & Cure Awards

NEW YORK, NY – The Crohn’s & Colitis Foundation announced today that it is presenting its Uniting to Care & Cure Awards to 16 healthcare providers from across the country in recognition of their work to help find cures for inflammatory bowel disease (IBD) and improve the quality of life o

June 11, 2021

Crohn’s & Colitis Foundation Names New Chair to Lead National Scientific Advisory Committee

NEW YORK, NY – The Crohn’s & Colitis Foundation (the Foundation) has named Dr. David T.

June 10, 2021

Mediterranean Style Diet and Specific Carbohydrate Diet™ Can Improve Symptoms of Patients with Crohn’s Disease

New York, NY – For Crohn’s disease patients with mild-to-moderate symptoms, a Mediterranean style diet and the Specific Carbohydrate Diet™ appear to improve symptoms and quality of life, according to a new study published in

May 28, 2021

Crohn’s & Colitis Foundation Receives $3.3 Million from The Helmsley Charitable Trust to Improve Urgent Care Management of Crohn’s Disease

The Crohn’s & Colitis Foundation announced today that it has received a $3.3 million grant from The Leona M. and Harry B. Helmsley Charitable Trust to improve the urgent care management of Crohn’s disease through IBD Qorus®, the Foundation’s flagship quality of care program. 

May 12, 2021

Progenity Receives Funding from Crohn’s & Colitis Foundation IBD Ventures Fund to Develop Drug Delivery System for IBD

Progenity, Inc., a biotechnology company with an established track record of success developing and commercializing molecular testing products, announced today that it has received funding from the Crohn’s & Colitis Foundation’s IBD Ventures program to further develop Progenity’s first-in-class oral Drug Delivery System (DDS) for delivery of targeted therapeutics for inflammatory bowel disease (IBD).

May 11, 2021

Crohn’s & Colitis Foundation Names New Board Chair, Elects Three New Trustees

NEW YORK, NY – The Crohn’s & Colitis Foundation announced today that Dr. Brent Polk (University of California San Diego) has been appointed Chair of its national Board of Trustees, and that three new trustees have been elected to the Board.

March 11, 2021

New Spill Your Guts Campaign from the Crohn’s & Colitis Foundation Inspires People to Speak Up About Their Symptoms

NEW YORK, NY – The Crohn's & Colitis Foundation, the leading non-profit dedicated to finding cures for inflammatory bowel disease (IBD) and improving patient quality of life, launched a new public service announcement (PSA) campaign to increase familiarity with the symptoms of Crohn’s disease

February 18, 2021

New Partnership Announced to Develop First Prognostic Tests for Pediatric Crohn's Disease

The Crohn's and Colitis Foundation enters partnership with LifeArc to develop first clinical tests to predict disease course and response to treatment in pediatric Crohn's patients.

January 25, 2021

Crohn’s & Colitis Foundation and Pfizer, Inc. Announce Funding Awards to Reduce Health Disparities in Patients with Inflammatory Bowel Disease

NEW YORK, NY – The Crohn’s & Colitis Foundation (Foundation), in partnership with Pfizer Inc., has announced the results of a request for proposal (RFP) to reduce health disparities that exist around vaccine usage and health maintenance in patients with inflammatory bowel disease (IBD). 

October 7, 2020